Screen Readers Skip to Content

Interferons - Facts and Information

Published : 2010-07-23 - Updated : 2018-03-16
Author : Thomas C. Weiss - Contact: disabled-world.com

Synopsis* : Interferons are a group of proteins that are produced in a persons body in response to an attack by a virus.

Main Digest

Interferons are a group of proteins that are produced in a person's body in response to an attack by a virus.

When a cell becomes infected by a virus, it releases tiny amounts of, 'interferons,' which then attach themselves to neighboring cells and prompt them to begin producing their own protective antiviral enzymes. The result of these actions is an impairment of the replication and growth of the attacking virus. Interferon has also been demonstrated to have some anti-tumor properties.

There are three known classes of interferons; alpha, beta, and gamma.

They are currently being used by doctors to treat diseases involving a person's immune system such as hepatitis, cancer, multiple sclerosis, AIDS, perianal and genital warts, as well as granulomatous disease. While interferons were discovered in the 1950's by Scottish virologist Alick Isaacs, medical use of them was not practical until recombinant DNA techniques of genetic engineering made it possible to mass produce them.

Each class of interferons has a number of effects, although their effects overlap one another.

The commercially-available forms of interferons are human ones, manufactured using recombinant DNA technology. The mechanisms involved in the actions of interferons are complex and are not very well understood at this time.

What is known is that interferons modulate the response of the human immune system to bacteria, viruses, cancer, and additional foreign substances that invade a person's body. While interferons do not directly kill cancerous or viral cells, they do boost a person's immune system in response while reducing the growth of cancer cells through regulation of the action of several genes which control the secretion of numerous cellular proteins that affect growth. Due to the fact that interferons enhance a person's immune system in a number of ways, they are used for various disease involving the immune system. Some examples include the following.

Inteferons, despite being very similar to each other, affect a person's body in different ways. Due to the varying affects, different interferons are us for different conditions. Interferon alphas are used in the treatment of viral infections and cancers, while interferon betas are used in the treatment of multiple sclerosis. Interferon gamma is used in the treatment of chronic grandulomatous disease.

Potential Side-Effects of Interferons:

People who receive treatment with interferons may experience flu-like symptoms following injections such as chills, headache, fever, malaise, muscle aches and pains. The symptoms can vary from mild to severe and occur in up to fifty-percent of people who receive treatments. The symptoms tend to diminish as the person receives repeated injections and can be managed with medications such as acetaminophen, or antihistamines such as diphenhydramine. People receiving interferon treatment may also experience tissue damage at the injection site, something that occurs more commonly with interferon beta-1b and pegylated interferon alfa-2b.

Both depression and suicide have been reported among people receiving interferon treatment. It is important to note that it is unclear whether or not depression and suicidal thoughts are caused by the diseases being treated with interferons, or the interferons themselves. People receiving interferon treatment should be observed for signs of depression and suicidal ideation.

Additional side-effects that can occur in association with interferon treatment, and may be caused by administration of higher dosages include:

Interferon alfa-2a, interferon alfa-2b, and interferon beta-1b can increase levels of zidovudine, also known as, 'AZT,' or, 'Retrovir,' in a person's blood. Although the reaction can improve the effectiveness of zidovudine, it may also increase the person's risk for liver and blood toxicity. The person's dosage of zidovudine may need to be reduced by as much as seventy-five percent while receiving interferon treatments. Interferon alfa-2a and interferon alfa-2b can increase the amount of time it takes for theophylline to be eliminated from a person's body; their dose of theophylline might need to be reduced while receiving interferon treatments.

Available forms of interferons include:

About the Author

Thomas C. Weiss attended college and university courses earning a Masters, Bachelors and two Associate degrees, as well as pursing Disability Studies. As a Nursing Assistant Thomas has assisted people from a variety of racial, religious, gender, class, and age groups by providing care for people with all forms of disabilities from Multiple Sclerosis to Parkinson's; para and quadriplegia to Spina Bifida.

You're reading Disabled World. Be sure to check out our homepage for further informative disability news, reviews, disability sports events, exclusive stories and how-tos. You can also find us on Twitter, Facebook, and LinkedIn.

Related Asthma Documents

*Disclaimer: Disabled World provides general information only. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World. View our Advertising Policy for further information. Please report outdated or inaccurate information to us.

Cite Page: Journal: Disabled World. Language: English (U.S.). Author: Thomas C. Weiss. Electronic Publication Date: 2010-07-23 - Revised: 2018-03-16. Title: Interferons - Facts and Information, Source: <a href=https://www.disabled-world.com/health/respiratory/asthma/interferons.php>Interferons - Facts and Information</a>. Retrieved 2021-05-09, from https://www.disabled-world.com/health/respiratory/asthma/interferons.php - Reference: DW#172-4727.